弹性纤维性假黄瘤合并Graves病1例及文献复习
|
摘要
<正>1病历摘要患者,女,40岁,以"发现颈部皮疹3年余"为主诉就诊笔者医院。3年余前无明显诱因发现双侧颈部起丘疹,逐渐增多,融合并蔓延至颈前,无疼痛瘙痒等不适,未诊治。自诉心悸气短,焦躁易怒,既往患有"弥漫性毒性甲状腺肿(Graves病)"1年,未诊治。否认其父母为近亲结婚,家族中无类似病史。体格检查:甲状腺Ⅱ度肿大,余系统检查无明显
引文
[1] Kauffenstein G,Yegutkin G G,Khiati S,et al. Alteration of extracellular nucleotide metabolism in pseudoxanthoma elasticum[J]. J Invest Dermatol,2018,22(18):30148-30149.
[2] Ebran J M, Martin L,Leftheriotis,et al. Subretinal fibrosis is associated with fundus pulverulentus in pseudoxanthoma elasticum[J].Graefes Arch Clin Exp Ophthalmol,2018,10(18):3937-3945.
[3] Maarouf M,Sharon V R,Sivamani R K,et al. Familial pseudoxanthoma elasticum associated with multiple comedones[J]. Dermatol Online J,2017,23(9):1-2.
[4] Kranenburg G,Visseren F L J,de Borst G J,et al. Arterial stiffening and thickening in patients with pseudoxanthoma elasticum[J].Atherosclerosis,2018,3(270):160-165.
[5] Kawashima S,Togawa Y,Miyachi H,et al. Dermoscopic features of pseudoxanthoma elasticum[J].Clin Exp Dermatol,2018,43(2):175-179.
[6] Gliem M,Müller P L,Birtel J,et al. Quantitative fundus autofluorescence in pseudoxanthoma elasticum[J]. Invest Ophthalmol Vis Sci,2017,58(14):6159-6165.
[7] Yoo J Y,Blum R R,Singer G K,et al. A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum[J].Jam Acad Dermatol,2011,65(2):341-348.
[8] Tomer Y,Barbesino G,Keddache M,et al. Mapping of a major susceptibility locus for Graves′ disease (GD21) to chromosome 14q31[J]. Clin Endocrinol Metab,1997,82(5):1645-1648.
[9] Moitra K,Garcia S,Jaldin M,et al. ABCC6 and pseudoxanthoma elasticum: the face of a rare disease from genetics to advocacy[J]. Int J Mol Sci,2017,18(7):1488.
[2] Ebran J M, Martin L,Leftheriotis,et al. Subretinal fibrosis is associated with fundus pulverulentus in pseudoxanthoma elasticum[J].Graefes Arch Clin Exp Ophthalmol,2018,10(18):3937-3945.
[3] Maarouf M,Sharon V R,Sivamani R K,et al. Familial pseudoxanthoma elasticum associated with multiple comedones[J]. Dermatol Online J,2017,23(9):1-2.
[4] Kranenburg G,Visseren F L J,de Borst G J,et al. Arterial stiffening and thickening in patients with pseudoxanthoma elasticum[J].Atherosclerosis,2018,3(270):160-165.
[5] Kawashima S,Togawa Y,Miyachi H,et al. Dermoscopic features of pseudoxanthoma elasticum[J].Clin Exp Dermatol,2018,43(2):175-179.
[6] Gliem M,Müller P L,Birtel J,et al. Quantitative fundus autofluorescence in pseudoxanthoma elasticum[J]. Invest Ophthalmol Vis Sci,2017,58(14):6159-6165.
[7] Yoo J Y,Blum R R,Singer G K,et al. A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum[J].Jam Acad Dermatol,2011,65(2):341-348.
[8] Tomer Y,Barbesino G,Keddache M,et al. Mapping of a major susceptibility locus for Graves′ disease (GD21) to chromosome 14q31[J]. Clin Endocrinol Metab,1997,82(5):1645-1648.
[9] Moitra K,Garcia S,Jaldin M,et al. ABCC6 and pseudoxanthoma elasticum: the face of a rare disease from genetics to advocacy[J]. Int J Mol Sci,2017,18(7):1488.